SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-001842
Filing Date
2017-03-21
Accepted
2017-03-21 14:00:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a2231479z424b5.htm 424B5 363648
2 G983809.JPG g983809.jpg GRAPHIC 16912
3 G186436.JPG g186436.jpg GRAPHIC 94907
4 G179565.JPG g179565.jpg GRAPHIC 18165
  Complete submission text file 0001047469-17-001842.txt   544029
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214859 | Film No.: 17703779
SIC: 2834 Pharmaceutical Preparations